Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis: Results from IMPACT 2 trial

被引：0
|
作者：
Van der Heljde, D
Kavanaugh, A
Beutler, A
Guzzo, C
Zhou, B
Dooley, L
Antonl, CE
Krueger, GG
Gladman, D
机构：
[1] Univ Hosp Maastricht, Dept Rheumatol, Maastricht, Netherlands
[2] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[3] Centocor Inc, Clin Res & Dev, Malvern, PA 19355 USA
[4] Univ Erlangen Nurnberg, Dept Med 3, Erlangen, Germany
[5] Univ Utah, Hlth Sci Ctr, Dept Dermatol, Salt Lake City, UT USA
[6] Univ Toronto, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [41] Infliximab inhibits radiographic progression in some patients with ankylosing spondylitis
    Katherine Sole
    Nature Clinical Practice Rheumatology, 2006, 2 (1): : 8 - 9
  • [42] PROGRESSION OF RADIOGRAPHIC AXIAL DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS. RELATION WITH CLINICAL AND ANALYTICAL FACTORS
    Quesada, A.
    Sanchez, M. D.
    Perez, L.
    Usategui, R.
    Manzano, G.
    Hidalgo, C.
    Martinez, O.
    del Pino, J.
    Montilla, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 595 - 595
  • [43] Progression of Radiographic Axial Damage in Patients with Psoriatic Arthritis. Relation with Clinical and Analytical Factors
    Quesada-Moreno, Alba
    Dolores Sanchez-Gonzalez, Maria
    Perez-Garrido, Laura
    Usategui-Martin, Ricardo
    Manzano-Canabal, Guadalupe
    Hidalgo-Calleja, Cristina
    Martinez-Gonzalez, Olga
    Del Pino-Montes, Javier
    Alberto Montilla-Morales, Carlos
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [44] Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the infliximab multinational psoriatic Arthritis Controlled Trial (IMPACT) (vol 52, pg 1227, 2005)
    Antoni, CE
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2951 - 2951
  • [45] Male Gender is Associated with Accelerated Radiographic Progression in Axial Damage but not with Progression of Peripheral Damage in Psoriatic Arthritis
    Eder, Lihi
    Thavaneswaran, Arane
    Chandran, Vinod
    Gladman, Dafna
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 990 - 990
  • [46] Secukinumab provides sustained inhibition of radiographic progression in active psoriatic arthritis patients: 52-week results from future 5 study
    Mease, P.
    Heijde, D. V. D.
    Landewe, R.
    Mpofu, S.
    Rahman, P.
    Tahir, H.
    Singhal, A.
    Boettcher, E.
    Navarra, S.
    Zhu, X.
    Readie, A.
    Pricop, L.
    Abrams, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 84 - 84
  • [47] Sustained improvement in clinical measures of psoriatic arthritis in infliximab-treated patients: 1 year results from impact 2
    Kavanaugh, A.
    Antoni, C.
    Krueger, G. G.
    Gladman, D. D.
    Birbara, C.
    Boling, E.
    Siegel, E.
    Halter, D.
    Geusens, P.
    De Vlam, K.
    Kirkham, B.
    Beutler, A.
    Guzzo, C.
    Zhou, B.
    Dooley, L. T.
    Mease, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 220 - 221
  • [48] Secukinumab inhibits radiographic progression in patients with psoriatic arthritis: Results of phase 3 FUTURE 1 study stratified by concomitant methotrexate use
    Gottlieb, Alice
    Mease, Philip
    McInnes, Iain
    Mpofu, Shephard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB271 - AB271
  • [49] Infliximab therapy results in sustained improvement in functional status and quality of life in patients with psoriatic arthritis - Results from the IMPACT 2 study.
    Kavanaugh, A
    Antoni, CE
    Krueger, GG
    Geusens, P
    de Vlam, K
    Birbara, C
    Beutler, A
    Zhou, B
    Dooley, LT
    Guzzo, C
    Wu, Y
    Bala, M
    Gladman, D
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S210 - S210
  • [50] Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study
    Mease, Philip
    van der Heijde, Desiree
    Landewe, Robert
    Mpofu, Shephard
    Rahman, Proton
    Tahir, Hasan
    Singhal, Atul
    Boettcher, Elke
    Navarra, Sandra
    Meiser, Karin
    Readie, Aimee
    Pricop, Luminita
    Abrams, Ken
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (06) : 890 - 897
12345